Hormone Replacement Therapy and Risk of Breast Cancer in Korean Women: A Quantitative Systematic Review.
- Author:
Jong Myon BAE
1
;
Eun Hee KIM
Author Information
- Publication Type:Meta-Analysis ; Research Support, Non-U.S. Gov't ; Review
- Keywords: Breast neoplasms; Risk factors; Hormone replacement therapy; Meta-analysis
- MeSH: Breast Neoplasms/epidemiology/*etiology; Databases, Factual; Female; *Hormone Replacement Therapy; Humans; Incidence; Republic of Korea/epidemiology; Risk
- From:Journal of Preventive Medicine and Public Health 2015;48(5):225-230
- CountryRepublic of Korea
- Language:English
- Abstract: OBJECTIVES: The epidemiological characteristics of breast cancer incidence by age group in Korean women are unique. This systematic review aimed to investigate the association between hormone replacement therapy (HRT) and breast cancer risk in Korean women. METHODS: We searched electronic databases such as KoreaMed, KMbase, KISS, and RISS4U as well as PubMed for publications on Korean breast cancer patients. We also conducted manual searching based on references and citations in potential papers. All of the analytically epidemiologic studies that obtained individual data on HRT exposure and breast cancer occurrence in Korean women were selected. We restricted the inclusion of case-control studies to those that included age-matched controls. Estimates of summary odds ratio (SOR) with 95% confidence intervals (CIs) were calculated using random effect models. RESULTS: One cohort and five case-control studies were finally selected. Based on the heterogeneity that existed among the six studies (I-squared=70.2%), a random effect model was applied. The summary effect size of HRT history from the six articles indicated no statistical significance in breast cancer risk (SOR, 0.983; 95% CI, 0.620 to 1.556). CONCLUSIONS: These facts support no significant effect of HRT history in the risk of breast cancer in Korean women. It is necessary to conduct a pooled analysis.
